New York State Common Retirement Fund’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Hold
4,200
﹤0.01% 2546
2026
Q1
$84.7K Hold
4,200
﹤0.01% 2599
2025
Q4
$86.5K Hold
4,200
﹤0.01% 2673
2025
Q3
$72.8K Hold
4,200
﹤0.01% 2814
2025
Q2
$62.8K Hold
4,200
﹤0.01% 2878
2025
Q1
$49.2K Hold
4,200
﹤0.01% 2780
2024
Q4
$96K Hold
4,200
﹤0.01% 2610
2024
Q3
$176K Hold
4,200
﹤0.01% 2357
2024
Q2
$153K Buy
+4,200
New +$148K ﹤0.01% 2548
2022
Q3
Sell
-15
Closed 3392
2022
Q2
$0 Sell
15
-705
-98% -$17.2K ﹤0.01% 3518
2022
Q1
$27K Hold
720
﹤0.01% 3262
2021
Q4
$69K Sell
720
-964
-57% -$117K ﹤0.01% 3161
2021
Q3
$243K Sell
1,684
-650
-28% -$99.5K ﹤0.01% 2838
2021
Q2
$431K Sell
2,334
-244
-9% -$54K ﹤0.01% 2683
2021
Q1
$635K Hold
2,578
﹤0.01% 2334
2020
Q4
$727K Sell
2,578
-25
-1% -$6.11K ﹤0.01% 2172
2020
Q3
$625K Buy
2,603
+83
+3% +$20.1K ﹤0.01% 2114
2020
Q2
$837K Buy
+2,520
New +$657K ﹤0.01% 1961

Other funds holding NGNE

New York State Common Retirement Fund's NGNE Position: Q2 2026 in Review

New York State Common Retirement Fund held its Neurogene (NGNE) position steady in Q2 2026 at 4,200 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #2546.

New York State Common Retirement Fund first reported a position in NGNE in Q2 2020 and has held it in 18 quarters since. The position peaked at $837K in Q2 2020. 16 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • New York State Common Retirement Fund held 4,200 shares of Neurogene worth $132K as of Q2 2026.
  • New York State Common Retirement Fund left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2546 holding.
  • New York State Common Retirement Fund first reported a position in Neurogene in Q2 2020 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Neurogene position peaked at $837K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.